Previously, we showed that the extracellular domains of EphA2 and CD44 can be displayed on the yeast cell surface and used to identify mAbs from a phage antibody library pre-selected on breast cancer cells overexpressing EphA2 and CD44 [23]. This evidence concerns the gene EPHA2 and breast cancer.